TOP1 and cancer: In this regard, our results of animal studies revealed that CPT treatment (1 mg/kg body weight) significantly reduced WRN‐depleted melanoma, as compared to WRN‐proficient melanoma, indicating translational potential of TOP1 inhibitor therapy for cancer patients with WRN deficiency.